Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2012
09/19/2012CN102675281A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/18/2012US8268852 Heterocyclic inhibitors of MEK and methods of use thereof
09/18/2012US8268790 Dermatalogical formulations
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/12/2012EP2497488A1 Method for treating delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA
09/12/2012EP2497487A1 Method for treating diabetes and atherosclerosis associated with changes of qualitative and/quantitative composition of blood extracellular DNA
09/12/2012EP2497486A1 Method for treating diseases caused by fungi associated with changes of qualitative and/quantitative composition of blood extracellular DNA
09/12/2012EP2497478A2 Oligosaccaride compositions and use thereof in the treatment of infection
09/11/2012US8263659 Thyroid receptor ligands
09/11/2012US8263378 Human β-adrenergic receptor kinase polypeptide and methods
09/11/2012US8263093 Methods and compositions for administration of TRPV1 agonists
09/11/2012US8263074 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
09/11/2012CA2519112C Optimized expression of hpv 31 l1 in yeast
09/11/2012CA2513227C Methods for site-directed mutagenesis and targeted randomization
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/06/2012US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
09/05/2012EP2495314A1 Novel vaccine composition
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8257754 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
09/04/2012US8257751 Composition for the cosmetic treatment of age-related dermatological symptoms
08/2012
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012US20120216802 Composition for inhalation
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252839 Compounds and methods for delivery of prostacyclin analogs
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012CA2526626C Emulsion base for skin care compositions
08/28/2012CA2506319C Stents comprising biodegradable polymers associated with therapeutic agents
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/23/2012US20120214774 Treatment of solid tumors with rapamycin derivatives
08/23/2012US20120214233 Cystatin c as an antagonist of tgf-beta and methods related thereto
08/23/2012US20120213816 Mycoplasma hyopneumoniae bacterin vaccine
08/22/2012EP1644021B1 Methods and compositions for the treatment of gastrointestinal disorders
08/22/2012CN1960704B Composition, compising hydrofluoric acid, for inhibiting dental erosion
08/21/2012US8246996 comprising immediate release, sustained release and delayed release dosage forms, with each dosage forms having a different release profile, wherein each reaches a maximum concentration at different times
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012CA2530075C Amphiphilic pyridinium compounds, method of making and use thereof
08/21/2012CA2527112C 2-aminobenzoyl derivatives as nmda receptor antagonists
08/21/2012CA2499600C Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
08/16/2012US20120208203 Compositions and methods for modulating c-rel-dependent cytokine production
08/16/2012US20120207783 Hiv vaccine formulations
08/16/2012US20120207782 Hiv dna vaccine regulated by a caev-derived promoter
08/16/2012US20120207738 Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
08/16/2012US20120207732 Compositions and methods for promoting neuronal outgrowth
08/15/2012EP1615633B1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/15/2012EP1594524B1 Use of tryptanthrin compounds for immune potentiation
08/15/2012CN1867550B Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN101282741B Method for treating or preventing ischemia reperfusion injury or multi-organ failure
08/14/2012US8242146 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents
08/14/2012US8242101 Leukemia treatment method and composition
08/09/2012US20120203052 Therapeutic regimen for treating cancer
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP1933861B1 Method for treating or preventing multi-organ failure
08/08/2012EP1635763B1 Method of treating neurodegenerative disease
08/08/2012EP1594508B1 Novel bicyclic compounds and compositions
08/08/2012CN1816331B Tumor-targeting drug-loaded particles
08/08/2012CN101107003B Homeopathic formulations useful for treating pain and/or inflammation
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236800 antimicrobial agents and antidote for hemorrhagic complications associated with heparin therapy; peptide having optimal sites of polar and nonpolar substituents that confer amphiphilic properties; leucine and aminobenzoic acid derivative; isophthalic acid and diaminobenzene, 3-tert-butyl-6-alkylthio cmpd
08/02/2012US20120196797 Methods and Compositions for the Treatment of Gastrointestinal Disorders
08/02/2012US20120195855 Methods for up-regulating antigen expression in tumors
08/01/2012EP2481743A1 LPA receptor agonists and antagonists and methods of use
08/01/2012EP2481422A2 Multiplex vaccines
08/01/2012EP1553966B1 Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof
08/01/2012EP1545634B1 Method of preparing dry powder inhalation compositions
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
07/2012
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/31/2012US8232316 Compounds and methods for delivery of prostacyclin analogs
07/31/2012US8232255 Methods for vaccinating against malaria
07/31/2012US8232247 Methods of treating cancer, arthritis and/or diabetes with angiopoietins
07/31/2012US8231648 Nosebleed lip pack
07/26/2012US20120190717 Methods and compositions for increasing the anaerobic working capacity in tissues
07/25/2012EP1811995B1 A transmucosal veterinary composition comprising detomidine
07/25/2012EP1605897B1 Polyethelene glycol link glp-1 compounds
07/25/2012EP1592457B1 Folate-vinblastine conjugate as medicament
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/24/2012US8227471 Treating sexual desire disorders with flibanserin
07/24/2012US8226988 Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same
07/24/2012CA2517427C Antiprotozoal imidazopyridine compounds
07/24/2012CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120183634 Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
07/18/2012EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors
07/18/2012EP2476415A2 Treating bone-related disorders with selective androgen receptor modulators
07/18/2012EP1608648B1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
07/18/2012CN1723041B Stable immunogenic product comprising antigenic heterocomplexes
07/18/2012CN102586205A Combination of enzyme with enzymatic active site-specific chaperones
07/18/2012CN102584813A Compouds and uses thereof in modulating amyloid beta
07/18/2012CN102584788A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/18/2012CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization
07/18/2012CN102580067A Combination therapy for treating protein deficiency disorders
07/18/2012CN102580066A Combination therapy for treating protein deficiency disorders
07/18/2012CN102579427A Synthetic lactone formulations and method of use
07/18/2012CN101863878B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 295